OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
OPKO Health, Inc. filed this Current Report on Form 8-K on November 8, 2010, to disclose a material accounting error and the subsequent restatement of previously issued financial statements. The restatement affects the consolidated financial statements for the year ended December 31, 2009, and interim periods ended September 30, 2009, March 31, 2010, and June 30, 2010.
Key Financial Metrics and Restatement Impact
The filing does not report new operational revenue, profit, or cash flow figures for the current period. Instead, it details adjustments to historical financial data resulting from the improper accounting of the September 28, 2009, Series D Convertible Preferred Stock offering. The error involved failing to allocate $30 million in proceeds between the Preferred Stock and warrants based on relative fair values, resulting in an unrecorded $3.9 million beneficial conversion feature.
| Balance Sheet Impact (in thousands) | Adjustment |
|---|---|
| Series D Preferred Stock (Reclassified to Mezzanine) | $26,128 |
| Additional Paid-in Capital | ($26,116) |
| Total Shareholders' Equity | ($26,128) |
The restatement also impacts the Statement of Operations by recognizing a deemed dividend, which increases the net loss attributable to common shareholders.
| Income Statement Impact (in thousands) | Period | Adjustment to Net Loss Attributable to Common |
|---|---|---|
| Three months ended Sept 30, 2009 | ($3,872) | |
| Nine months ended Sept 30, 2009 | ($3,872) | |
| Year ended Dec 31, 2009 | ($3,872) |
Material Changes Versus Prior Period
The primary material change is the reclassification of the Series D Preferred Stock from a component of equity to the mezzanine section of the balance sheet. Additionally, the filing corrects the calculation of net loss attributable to common shareholders by adding a $3.872 million deemed dividend for the affected periods. Consequently, the reported loss per share for these periods increases (becomes more negative) by $0.02 per share.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, outlook, or management commentary regarding future operations. The primary risk disclosed is the reliability of previously issued financial statements, which the Audit Committee concluded should no longer be relied upon. The Company is filing amendments to its Form 10-K for 2009 and Form 10-Qs for the first two quarters of 2010 to reflect these restatements. The Audit Committee has discussed these matters with Ernst & Young LLP, the independent registered public accounting firm.
Key Facts for Investor Verification
- Verify the amended Form 10-K for the year ended December 31, 2009, and amended Form 10-Qs for March 31, 2010, and June 30, 2010, for updated financial figures.
- Confirm the reclassification of $26.128 million of Series D Preferred Stock to the mezzanine section of the balance sheet.
- Note that the net loss attributable to common shareholders for the affected periods is higher than previously reported due to the $3.872 million deemed dividend adjustment.
- Review the press release dated November 9, 2010 (Exhibit 99.1), for further details on the restatement process.